Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001420720-25-000025
Filing Date
2025-05-02
Accepted
2025-05-02 08:29:28
Documents
105
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ibio-20250331x10q.htm   iXBRL 10-Q 2198414
2 EX-10.3 ibio-20250331xex10d3.htm EX-10.3 33574
3 EX-31.1 ibio-20250331xex31d1.htm EX-31.1 15609
4 EX-31.2 ibio-20250331xex31d2.htm EX-31.2 18634
5 EX-32.1 ibio-20250331xex32d1.htm EX-32.1 10488
6 EX-32.2 ibio-20250331xex32d2.htm EX-32.2 6604
7 EX-4.1 ibio-20250331xex4d1.htm EX-4.1 34254
8 GRAPHIC ibio-20250331x10q001.jpg GRAPHIC 51711
9 GRAPHIC ibio-20250331x10q002.jpg GRAPHIC 104987
10 GRAPHIC ibio-20250331x10q003.jpg GRAPHIC 70535
11 GRAPHIC ibio-20250331x10q005.jpg GRAPHIC 95402
  Complete submission text file 0001420720-25-000025.txt   12528692

Data Files

Seq Description Document Type Size
12 EX-101.SCH ibio-20250331.xsd EX-101.SCH 78859
13 EX-101.CAL ibio-20250331_cal.xml EX-101.CAL 60235
14 EX-101.DEF ibio-20250331_def.xml EX-101.DEF 471499
15 EX-101.LAB ibio-20250331_lab.xml EX-101.LAB 594975
16 EX-101.PRE ibio-20250331_pre.xml EX-101.PRE 682850
108 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20250331x10q_htm.xml XML 1911268
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 25905577
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)